Skip to content

Age Related Macular Degeneration 4 C1853147

Published: July 22, 2026Updated: August 20, 2026

Age-related macular degeneration (AMD) causes deterioration of the central retina, primarily affecting older adults. Various treatments are available to help manage the condition and maintain vision.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Central visual loss

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Metamorphopsia

(ophthalmologic)

Photopsia

(ophthalmologic)

Visual hallucinations (Charles Bonnet syndrome)

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-VEGF therapy

Monoclonal antibody fragments administered via intravitreal injection to block VEGF-mediated angiogenesis. Standard first-line treatment for wet AMD presentations.

medication
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Lutein and zeaxanthin supplementation

Carotenoid supplementation specifically formulated for macular pigment enhancement. Part of the AREDS2 formulation proven to benefit intermediate AMD patients.

dietary

Additional treatment options

Photodynamic therapy

Verteporfin-based treatment activated by non-thermal red light to selectively occlude choroidal neovascularization while preserving retinal architecture.

procedure

UV-protective eyewear

Wraparound sunglasses with 100% UVA/UVB protection to reduce oxidative retinal damage. Indoor blue-light filtering may provide additional protection.

lifestyle

Fundus autofluorescence imaging

Non-invasive imaging to assess lipofuscin distribution and RPE health, providing prognostic information about AMD progression.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Age Related Macular Degeneration 4 C1853147?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Singer M, Bressler SB, Brown GC, Ehrlich R, Friberg TR, Ho AC, Huang SS, Ip MS, Kulkarni AD, Punjabi OS, Stone EM, Wykoff CC. Age-Related Macular Degeneration Preferred Practice Pattern. Ophthalmology. 2023;130(5):P1-P50.

guideline2023
2

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for Neovascular Age-Related Macular Degeneration: The MARINA Trial. N Engl J Med. 2006;355(14):1419-1431.

clinical_trial2006
3

Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147-1159.

review2018
4

Sarwar S, Clearfield E, Soliman MK, Sadiq MA, Baldwin AJ, Hanout M, Anwar MN, Sepah YJ, Do DV, Nguyen QD. Aflibercept for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2016;2(2):CD011346.

meta_analysis2016

Medication Comparisons

Compare medications used to treat Age Related Macular Degeneration 4 C1853147. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy